<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Clinical Medicine and Pharmacology</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Clinical Medicine and Pharmacology</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Клиническая медицина и фармакология</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2409-3750</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">34943</article-id>
   <article-id pub-id-type="doi">10.12737/2409-3750-2020-5-4-19-28</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Оригинальные исследования</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>original research</subject>
    </subj-group>
    <subj-group>
     <subject>Оригинальные исследования</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">MODERN VIEW ON THE PROBLEM OF OSTEOPOROSIS IN ANKYLOSING SPONDYLITIS</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>СОВРЕМЕННЫЙ ВЗГЛЯД НА ПРОБЛЕМУ ОСТЕОПОРОЗА ПРИ АНКИЛОЗИРУЮЩЕМ СПОНДИЛИТЕ</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Раскина</surname>
       <given-names>Татьяна Алексеевна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Raskina</surname>
       <given-names>Tat'yana Alekseevna</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Малышенко</surname>
       <given-names>О. С.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Malyshenko</surname>
       <given-names>O. S.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Пиригова</surname>
       <given-names>М. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Pirigova</surname>
       <given-names>M. V.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-3"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Летаева</surname>
       <given-names>М. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Letaeva</surname>
       <given-names>M. V.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-4"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Аверкиева</surname>
       <given-names>Ю. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Averkieva</surname>
       <given-names>Yu. V.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-4"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Кемеровский государственный медицинский университет Минздрава России</institution>
     <city>Кемерово</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Кемеровский государственный медицинский университет Минздрава России</institution>
     <city>Кемерово</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Кемеровский государственный медицинский университет Минздрава России</institution>
     <city>Кемерово</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">Кемеровский государственный медицинский университет Минздрава России</institution>
     <city>Кемерово</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-3">
    <aff>
     <institution xml:lang="ru">2Областной клинический госпиталь для ветеранов войн, Кемерово</institution>
     <city>Кемерово</city>
     <country>Россия</country>
    </aff>
    <aff>
     <institution xml:lang="en">2Областной клинический госпиталь для ветеранов войн, Кемерово</institution>
     <city>Кемерово</city>
     <country>Russian Federation</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-4">
    <aff>
     <institution xml:lang="ru">Кемеровская государственная медицинская академия</institution>
    </aff>
    <aff>
     <institution xml:lang="en">Kemerovo State Medical Academy </institution>
    </aff>
   </aff-alternatives>
   <volume>5</volume>
   <issue>4</issue>
   <fpage>19</fpage>
   <lpage>28</lpage>
   <self-uri xlink:href="https://zh-szf.ru/en/nauka/article/34943/view">https://zh-szf.ru/en/nauka/article/34943/view</self-uri>
   <abstract xml:lang="ru">
    <p>В исследование включено 72 мужчины с достоверным диагнозом АС, средний возраст – 43,2±9,1 года. Проводилось рентгенологическое исследование осевого скелета и периферических суставов, определялся HLA-B27. Активность заболевания оценивали с использованием индекса ВАSDАI, функциональные нарушения - с помощью индекса BASFI. МПК определяли методом двухэнергетической рентгеновской абсорбциометрии. Контрольную группу составили 74 практически здоровых мужчины, средний возраст - 46,7±0,9 лет.Учитывая хронический характер и бессимптомное течение остеопороза, задачей врачей, работающих с данной группой больных, является активный поиск остеопороза с использованием всех доступных диагностических методик с целью раннего выявления данного состояния и последующей коррекции проводимого медикаментозного лечения.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>The study included 72 men with a reliable diagnosis of AS, mean age – 43,2±9,1 years. X-ray examination of the axial skeleton and peripheral joints was carried out, HLA-B27 was determined. Disease activity was assessed using the index ВАSDАI, functional disorders with the help of the BASFI index. BMD was determined by two-energy x-ray absorptiometry. The control group consisted of 74 healthy men, mean age – 46,7±0,9 years. Given the chronic nature and asymptomatic course of osteoporosis, the task of doctors working with this group of patients is an active search for osteoporosis using all available diagnostic techniques for the early detection of this condition and subsequent correction of the drug treatment.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>анкилозирующий спондилит</kwd>
    <kwd>остеопороз</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>ankylosing spondylitis</kwd>
    <kwd>osteoporosis</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ревматология. Российские клинические рекомендации / под редакцией ЕЛ Насонова М.: ГЭОТАР-Медиа, 2017. 456 с. [Rheumatology. Russian clinical guidelines. Nasonov EL, editors. Moscow: GEOTAR-Media Publ., 2017.456 p. (In Russ.)].</mixed-citation>
     <mixed-citation xml:lang="en">Revmatologiya. Rossiyskie klinicheskie rekomendacii / pod redakciey EL Nasonova M.: GEOTAR-Media, 2017. 456 s. [Rheumatology. Russian clinical guidelines. Nasonov EL, editors. Moscow: GEOTAR-Media Publ., 2017.456 p. (In Russ.)].</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Годзенко АА. Внескелетные проявления анкилозирующего спондилита: клиника, течение, прогноз: автореф. дис. … д-ра мед. наук. Москва, 2018. 38 с. [Godzenko AA. Non-skeletal manifestations of ankylosing spondylitis: clinic, course, prognosis. Dr. med. sci. abstracts diss. Moscow, 2018. 38 p. (In Russ.)].</mixed-citation>
     <mixed-citation xml:lang="en">Godzenko AA. Vneskeletnye proyavleniya ankiloziruyuschego spondilita: klinika, techenie, prognoz: avtoref. dis. … d-ra med. nauk. Moskva, 2018. 38 s. [Godzenko AA. Non-skeletal manifestations of ankylosing spondylitis: clinic, course, prognosis. Dr. med. sci. abstracts diss. Moscow, 2018. 38 p. (In Russ.)].</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Мясоутова ЛИ, Лапшина СА, Салихов ИГ. Изменение минеральной плотности костной ткани у больных анкилозирующим спондилоартритом. Остеопороз и остеопатии. 2011;(3):14-18 [Myasoutova LI,  Lapshina SA, Salikhov IG. The change in mineral bone density in patients with ankylosing spondylitis. Osteoporosis and osteopathy. 2011; (3):14-18 (In Russ.)].</mixed-citation>
     <mixed-citation xml:lang="en">Myasoutova LI, Lapshina SA, Salihov IG. Izmenenie mineral'noy plotnosti kostnoy tkani u bol'nyh ankiloziruyuschim spondiloartritom. Osteoporoz i osteopatii. 2011;(3):14-18 [Myasoutova LI,  Lapshina SA, Salikhov IG. The change in mineral bone density in patients with ankylosing spondylitis. Osteoporosis and osteopathy. 2011; (3):14-18 (In Russ.)].</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Губарь ЕЕ, Эрдес ШФ. Остеопороз у больных анкилозирующим спондилитом. Научно-практическая ревматология. 2013;51(5):53-62 [Gubar EE, Erdes SF. Osteoporosis in patients with ankylosing spondylitis. Rheumatology scienсe-practice. 2013;51(5):53-62  (In Russ.)].</mixed-citation>
     <mixed-citation xml:lang="en">Gubar' EE, Erdes ShF. Osteoporoz u bol'nyh ankiloziruyuschim spondilitom. Nauchno-prakticheskaya revmatologiya. 2013;51(5):53-62 [Gubar EE, Erdes SF. Osteoporosis in patients with ankylosing spondylitis. Rheumatology sciense-practice. 2013;51(5):53-62  (In Russ.)].</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Lange U, Kluge A, Strunk J et al. Ankylosing spondylitis and bone mineral density - what is the ideal tool for measurement? Rheumatol. Int. 2005;26(2):115-120.</mixed-citation>
     <mixed-citation xml:lang="en">Lange U, Kluge A, Strunk J et al. Ankylosing spondylitis and bone mineral density - what is the ideal tool for measurement? Rheumatol. Int. 2005;26(2):115-120.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Kaya A, Ozgocmen S, Kamanli A. et al. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes? Med. Princ. Pract.2009;18(6):470-476.</mixed-citation>
     <mixed-citation xml:lang="en">Kaya A, Ozgocmen S, Kamanli A. et al. Bone loss in ankylosing spondylitis: does syndesmophyte formation have an influence on bone density changes? Med. Princ. Pract.2009;18(6):470-476.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Беневоленская ЛИ, Лесняк ОМ. Остеопороз. Диагностика, профилактика и лечение. Клинические рекомендации. М.: ГЭОТАР-Медиа, 2011.14с. [Benevalenskaya  LI, Lesnyak OM. Osteoporosis. Diagnosis, prevention and treatment. Clinical guidelines. Moskow: GEOTAR-Media, 2011. 14p. (In Russ.)].</mixed-citation>
     <mixed-citation xml:lang="en">Benevolenskaya LI, Lesnyak OM. Osteoporoz. Diagnostika, profilaktika i lechenie. Klinicheskie rekomendacii. M.: GEOTAR-Media, 2011.14s. [Benevalenskaya  LI, Lesnyak OM. Osteoporosis. Diagnosis, prevention and treatment. Clinical guidelines. Moskow: GEOTAR-Media, 2011. 14p. (In Russ.)].</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Kim HR, Kim HY,  Lee SH. Elevated serum levels of soluble receptor activator of nuclear factors-kB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis. J. Rheumatology. 2006;45(10):1197-1200.</mixed-citation>
     <mixed-citation xml:lang="en">Kim HR, Kim HY,  Lee SH. Elevated serum levels of soluble receptor activator of nuclear factors-kB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis. J. Rheumatology. 2006;45(10):1197-1200.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Altindag O, Erel O, Soran N et al. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int. 2008;28:317-321.</mixed-citation>
     <mixed-citation xml:lang="en">Altindag O, Erel O, Soran N et al. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int. 2008;28:317-321.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009;44(5):772-776. doi: 10.1016/j.bone.2008.12.028.</mixed-citation>
     <mixed-citation xml:lang="en">Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone. 2009;44(5):772-776. doi: 10.1016/j.bone.2008.12.028.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Mermerci BB. Comparison of the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score in Turkish patients with ankylosing spondylitis. Clinical Rheumatology. 2009; 29(1):65-70.</mixed-citation>
     <mixed-citation xml:lang="en">Mermerci BB. Comparison of the Bath Ankylosing Spondylitis Radiology Index and the modified Stoke Ankylosing Spondylitis Spine Score in Turkish patients with ankylosing spondylitis. Clinical Rheumatology. 2009; 29(1):65-70.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ramirez J, Nieto-González JC, Curbelo Rodríguez R, Castañeda S, Carmona L. Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018; 48 (1): 44-52. doi: 10.1016/j.semarthrit.2017.12.001.</mixed-citation>
     <mixed-citation xml:lang="en">Ramirez J, Nieto-González JC, Curbelo Rodríguez R, Castañeda S, Carmona L. Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2018; 48 (1): 44-52. doi: 10.1016/j.semarthrit.2017.12.001.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Borcan M, Matei D, Popescu R. Management of osteoporosis in ankylosing spondylitis. Osteoporosis Int. 2011;22(1):309-310.</mixed-citation>
     <mixed-citation xml:lang="en">Borcan M, Matei D, Popescu R. Management of osteoporosis in ankylosing spondylitis. Osteoporosis Int. 2011;22(1):309-310.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Baskan BV, Dogan YP, Sivas F. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol. Int. 2010;30(3):375-381.</mixed-citation>
     <mixed-citation xml:lang="en">Baskan BV, Dogan YP, Sivas F. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis. Rheumatol. Int. 2010;30(3):375-381.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Lange U, Boss B, Teichmann J. et al. Serum amyloid A - an indicator of inflammation in ankylosing spondylitis . Reumatol. Int. 2000;19(4):119-122.</mixed-citation>
     <mixed-citation xml:lang="en">Lange U, Boss B, Teichmann J. et al. Serum amyloid A - an indicator of inflammation in ankylosing spondylitis . Reumatol. Int. 2000;19(4):119-122.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Braun J, van den Berg R, Baraliakos X et al. Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann. Rheum. Dis. 2011;70(6):896-904.</mixed-citation>
     <mixed-citation xml:lang="en">Braun J, van den Berg R, Baraliakos X et al. Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann. Rheum. Dis. 2011;70(6):896-904.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford). 2001;40(8):882-888.</mixed-citation>
     <mixed-citation xml:lang="en">Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford). 2001;40(8):882-888.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Capaci K, Hepguler S, Argin M. et al. Bone mineral density in mild and advanced ankylosing spondylitis. Yonsei Med. J. 2003;44(3):379-384.</mixed-citation>
     <mixed-citation xml:lang="en">Capaci K, Hepguler S, Argin M. et al. Bone mineral density in mild and advanced ankylosing spondylitis. Yonsei Med. J. 2003;44(3):379-384.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Gratacos J, Collado A, Pons F. et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis : follow up study. Arthritis Rheum. 1999;42(11):2319-2324.</mixed-citation>
     <mixed-citation xml:lang="en">Gratacos J, Collado A, Pons F. et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis : follow up study. Arthritis Rheum. 1999;42(11):2319-2324.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Derakhshan M, Goodson N, Packham J, et al. Hip osteoporosis and vertebral fractures are associated with younger age at diagnosis of spondyloarthritis: results from the comospa study. Annals of the Rheumatic Diseases. 2017;76:13083.</mixed-citation>
     <mixed-citation xml:lang="en">Derakhshan M, Goodson N, Packham J, et al. Hip osteoporosis and vertebral fractures are associated with younger age at diagnosis of spondyloarthritis: results from the comospa study. Annals of the Rheumatic Diseases. 2017;76:13083.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B21">
    <label>21.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Zhang Min et al. The association between ankylosing spondylitis and the risk of any, hip, or vertebral fracture: A meta-analysis. Medicine. 2017;96(50):8458.</mixed-citation>
     <mixed-citation xml:lang="en">Zhang Min et al. The association between ankylosing spondylitis and the risk of any, hip, or vertebral fracture: A meta-analysis. Medicine. 2017;96(50):8458.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B22">
    <label>22.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Feldtkeller E, Khan MA, van der Heijde D. et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol. Int. 2003;23(2):61-66.</mixed-citation>
     <mixed-citation xml:lang="en">Feldtkeller E, Khan MA, van der Heijde D. et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol. Int. 2003;23(2):61-66.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
